Table 4. Prevalence of risk factors for NCD and infectious diseasesa.
| Risk factor category | Sub-category | Prevalence n (%) | 95% CI |
| Anthropometric factors | Underweight (BMI<18.5 kg/m2) | 117 (23) | 20–27 |
| Normal weight (18.5≤BMI<25.0 kg/m2) | 241 (48) | 44–53 | |
| Overweight (25.0≤BMI<30.0 kg/m2) | 102 (20) | 17–24 | |
| Obese (BMI≥30.0 kg/m2) | 39 (8) | 5–10 | |
| Abdominal obesity (Males, waist circumference≥90 cm) | 50 (27) | 21–34 | |
| Abdominal obesity (Females, waist circumference≥80 cm) | 169 (53) | 48–59 | |
| Prehypertension (Systolic: 120–139 mmHg, Diastolic: 80–89 mmHg) | 195 (39) | 35–43 | |
| Hypertension (Systolic: ≥140 mmHg, Diastolic: ≥90 mmHg) | 90 (18) | 15–21 | |
| Biological factors | Pre-diabetes (A1c: 5.5–6.4%) | 185 (40) | 35–44 |
| Diabetes (A1c: ≥6.5%) | 37 (8) | 5–10 | |
| Borderline high cholesterol (Total cholesterol: 200–239 mg/dl) | 55 (12) | 9–14 | |
| Hypercholesterolaemia (Total cholesterol: ≥240 mg/dl) | 21 (4) | 3–6 | |
| Hepatitis B (all ages) | 153 (24) | 20–27 | |
| Hepatitis C (all ages) | 53 (8) | 6–10 | |
| Behavioral factors | Smoking tobacco users | 56 (12) | 9–16 |
| Smokeless tobacco users | 203 (45) | 41–50 | |
| Frequent use of therapeutic injections (>3 in 12 months) | 65 (8) | 6–10 |
a
Age ≥15 yrs unless otherwise specified.